Back to top
more

Fidelity MSCI Health Care Index ETF: (FHLC)

(Real Time Quote from BATS) As of Jul 24, 2024 01:28 PM ET

$70.83 USD

70.83
42,005

+0.49 (0.70%)

Volume: 42,005

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

Zacks News

Sweta Killa headshot

Healthcare ETFs in Focus as Q3 Earnings Unfold

The healthcare sector is expected to witness substantial earnings growth of 17.5% in the third quarter.

Sweta Killa headshot

Healthcare ETFs in Focus as Q2 Earnings Unfold

The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.

Sweta Killa headshot

Healthcare ETFs on Radar As Q1 Earnings Unfold

Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.

Sweta Killa headshot

Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

Sweta Killa headshot

Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

Sweta Killa headshot

What Lies Ahead for Healthcare ETFs in Q2 Earnings?

The healthcare sector is expected to witness substantial earnings decline of 6.9% in the second quarter, representing the second strongest sector this earnings season.

Sweta Killa headshot

Healthcare ETFs Looks Strong Ahead of Q1 Earnings

The healthcare sector has been on a tear driven by potential vaccines and treatments for COVID-19.

Sweta Killa headshot

What Lies Ahead for Healthcare ETFs in Q4 Earnings?

With earnings surprise in the cards, the healthcare sector is expected to witness substantial earnings growth of 4.4% in the fourth quarter, suggesting some room for potential upside for healthcare ETFs.

Sweta Killa headshot

What's in Store for Healthcare ETFs in Q3 Earnings?

With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.

Sweta Killa headshot

Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy

With earnings surprise in cards, the healthcare sector is expected to witness earnings growth of 1.7% in the second quarter, suggesting continued outperformance for healthcare ETFs.

Sweta Killa headshot

Can Q1 Earnings Lift Healthcare ETFs Higher?

With negative earnings revisions, the healthcare sector is expected to witness earnings growth of 1.8% in the first quarter, suggesting smooth trading for healthcare ETFs.

Sweta Killa headshot

Healthcare ETFs in Focus Ahead of Q4 Earnings

With lower negative earnings revisions, the healthcare sector is expected to witness earnings growth of 7.7% in the fourth quarter, suggesting continued outperformance for healthcare ETFs.

Sweta Killa headshot

Healthcare and Value: 2 ETFs to Watch on Outsized Volume

FHLC and SCHV saw massive trading volumes in the latest session.

Sweta Killa headshot

Healthcare ETFs to Buy Ahead of Q3 Earnings

The positive estimate revisions suggest continued outperformance for the healthcare ETFs.

Sweta Killa headshot

Healthcare ETFs to Buy on Solid Q2 Earnings Expectations

With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 9.1% in the second quarter, suggesting continued outperformance for healthcare ETFs.

    Sweta Killa headshot

    Quality and Healthcare: 2 ETFs to Watch on Outsized Volume

    QDF and FHLC saw massive volumes in yesterday trading session.